2021
DOI: 10.1016/j.ijrobp.2021.01.015
|View full text |Cite
|
Sign up to set email alerts
|

Cosmetic Outcomes of a Phase 1 Dose Escalation Study of 5-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer

Abstract: Purpose: Our purpose was to evaluate cosmetic changes after 5-fraction adjuvant stereotactic partial breast irradiation (S-PBI). Methods and Materials: Seventy-five women with in situ or invasive breast cancer stage 0, I, or II, with tumor size 3 cm, were enrolled after lumpectomy in a phase 1 dose escalation trial of S-PBI into cohorts receiving 30, 32.5, 35, 37.5,

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(15 citation statements)
references
References 44 publications
1
14
0
Order By: Relevance
“…49,50 Similar outcomes have been reported in additional prospective series, though they are limited by small numbers of patients and/or short follow-up. [48][49][50] Studies are currently underway evaluating these approaches further. [51][52][53][54] Proton therapy has also been used to deliver EBRT APBI regimens.…”
Section: Ultrashort Partial Breast Irradiationsupporting
confidence: 66%
See 1 more Smart Citation
“…49,50 Similar outcomes have been reported in additional prospective series, though they are limited by small numbers of patients and/or short follow-up. [48][49][50] Studies are currently underway evaluating these approaches further. [51][52][53][54] Proton therapy has also been used to deliver EBRT APBI regimens.…”
Section: Ultrashort Partial Breast Irradiationsupporting
confidence: 66%
“…[41][42][43][44][45][46][47] More recently, stereotactic APBI approaches have been considered to allow for further dose escalation. [48][49][50] A prospective dose escalation study with 75 patients beginning with 30 Gy/5 fractions and increasing to 40 Gy/5 fractions was performed; initial results were promising, with high rates of excellent/ good cosmetic outcomes and only 3 grade 3 toxicities reported with cosmetic outcomes stable at 3 years. 49,50 Similar outcomes have been reported in additional prospective series, though they are limited by small numbers of patients and/or short follow-up.…”
Section: Ultrashort Partial Breast Irradiationmentioning
confidence: 99%
“…The first results regarding cosmesis evaluated through the Harvard Breast Cosmesis Scale were published in 2021 ( 34 ): most patients reported excellent/good cosmesis at both baseline (86.3%) and year 3 (89.8%), and no cosmetic subdomain (telangiectasia, skin atrophy, scarring, pigment change, erythema, fat necrosis, and fibrosis) had significant worsening by year 3.…”
Section: Resultsmentioning
confidence: 99%
“…20 Excellent results have also been published for robotic stereotactic radiotherapy and proton PBI, with reduced heart and lung doses. [21][22][23] It is important to balance the additional resources required for these advanced techniques with the gain in long-term toxicity.…”
Section: Techniquementioning
confidence: 99%